Oncolytics Biotech (ONCY) Misses Q3 EPS by 2c

Oncolytics Biotech (NASDAQ: ONCY) reported Q3 EPS of ($0.12), $0.02 worse than the analyst estimate of ($0.10).

For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.

You May Also Be Interested In

• Citi upgrades Bath & Body Works to Buy with $25 price target
• PENN Entertainment (PENN) Reiterated at Market Outperform by Citizens as Relocation Announced
• Truist Securities Assumes Corcept Therapeutics (CORT) at Buy